Fragment Based Drug Discovery Market

Fragment-based Drug Discovery Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

  • Rep Id : TMRGL4741
  • Published On : Oct 2015
  • No. of Pages : 111
  • Category : Pharmaceutical


Chapter 1 Preface 
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology 
1.4 Research Methodology: Assumptions 

Chapter 2 Executive Summary 
2.1 Global Fragment-based Drug Discovery Market, Estimates and Forecast, By Revenue, 2013–2023 (US$ Mn) 
2.2 Global Fragment-based Drug Discovery Market Revenue, by Services, 2014 (US$ Mn) 
2.3 Global Fragment-based Drug Discovery Market Revenue, by End-user, 2014 (US$ Mn) 
2.4 Global Market Share, by Geography, 2014 and 2023 (Value %) 
2.5 Fragment-based Drug Discovery Market Snapshot 

Chapter 3 Fragment-based Drug Discovery Market Overview 
3.1 Introduction 
      3.1.1 Hit to Lead  
      3.1.2 Progression to Candidates from Fragment Leads 
3.2 Event Impact Analysis 
3.3 Future Trends and Developments 
3.4 Market Drivers 
      3.4.1 Simpler and less time consuming technique 
      3.4.2 Streamlining and easy access to advanced biophysical techniques
3.5 Restraints 
      3.5.1 Lower level of potency in few of the compounds derived from fragment screening  
      3.5.2 Requirement of high protein and unique fragment library for conducting studies 
3.6 Opportunities 
      3.6.1 Merging of computational biology with biophysical techniques 
      3.6.2 Emerging economies to offer sustained growth opportunities 
3.7 Porter’s Five Forces Analysis 
3.8 Recent Developments in Fragment-based Drug Discovery 
3.9 Fragment-based Drug Discovery: Case Histories 
3.10 Market Share – Fragment-based Drug Discovery Market (2014) (%)  
3.11 Market Attractiveness Analysis – Fragment-based Drug Discovery Market 

Chapter 4 Market Segmentation – By Services Component 
4.1 Introduction 
4.2 Comparative Analysis of FBDD and HTS 
4.3 Global Fragment Screening Market Revenue for FBDD, 2013 – 2023 (US$ Mn) 
      4.3.1 Global Biophysical Techniques Market for FBDD (US$ Mn), 2013 – 2023) 
             4.3.1.1 Global NMR Spectroscopy Market Revenue for FBDD, 2013–2023 (US$ Mn) 
             4.3.1.2 Global DSF Assay Market Revenue for FBDD, 2013–2023 (US$ Mn) 
             4.3.1.3 Global Fluorescence Polarization (FP) Market Revenue for FBDD, 2013–2023 (US$ Mn) 
             4.3.1.4 Global Isothermal Titration Calorimetry (ITC) Market Revenue for FBDD, 2013–2023 (US$ Mn) 
             4.3.1.5 Global X-ray Crystallography Market Revenue for FBDD, 2013–2023 (US$ Mn) 
             4.3.1.6 Global SPR Market Revenue for FBDD, 2013–2023 (US$ Mn) 
             4.3.1.7 Global Biolayer Interferometry Market Revenue for FBDD, 2013–2023 (US$ Mn) 
             4.3.1.8 Global Mass Spectrometry (MS) Market Revenue for FBDD, 2013–2023 (US$ Mn) 
             4.3.1.9 Global Capillary Electrophoresis (CE) Market Revenue for FBDD, 2013–2023 (US$ Mn) 
             4.3.1.10 Global Other (Biochemical Assays) Market Revenue for FBDD, 2013–2023 (US$ Mn) 
      4.3.2 Global Non-biophysical Techniques Market Revenue for FBDD, 2013–2023 (US$ Mn) 
4.4 Global Fragment Optimization Market Revenue for FBDD, 2013–2023 (US$ Mn) 

Chapter 5 Market Segmentation – By End-user 
5.1 Introduction 
5.2 Global Market for Fragment-based Drug Discovery in Biopharmaceutical Companies, 2013–2023 (US$ Mn) 
5.3 Global Market for Fragment-based Drug Discovery in CROs, 2013–2023 (US$ Mn) 
5.4 Global Market for Fragment-based Drug Discovery in Academic and Research Institutions, 2013–2023 (US$ Mn) 

Chapter 6 Fragment-based Drug Discovery Market - Regional Analysis 
6.1 Global Overview 
6.2 North America Fragment-based Drug Discovery Market Overview 
      6.2.1 U.S. Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn) 
      6.2.2 Canada Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn) 
6.3 Europe Fragment-based Drug Discovery Market Overview 
      6.3.1 Germany Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn) 
      6.3.2 U.K. Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn) 
      6.3.3 Rest of Europe Fragment-based Drug Discovery Market Revenue, 2013–2023 (US$ Mn) 
6.4 Asia Pacific Fragment-based Drug Discovery Market Revenue, 2013–2023 (US$ Mn) 
      6.4.1 Japan Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn) 
      6.4.2 Australia Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn) 
      6.4.3 Rest of Asia Pacific Fragment-based Drug Discovery Market Revenue, 2013–2023 (US$ Mn) 
6.5 LATAM Fragment-based Drug Discovery Market Revenue, 2013–2023 (US$ Mn) 
      6.5.1 Brazil Fragment-based Drug Discovery Market Revenue, 2013 - 2023, (US$ Mn) 
      6.5.2 Rest of LATAM Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn) 
6.6 RoW Fragment-based Drug Discovery Market Revenue, 2013–2023 (US$ Mn) 

Chapter 7 Company Profiles 
7.1 Astex Pharmaceuticals 
7.2 Alveus Pharmaceuticals Pvt. Ltd. 
7.3 Beactica AB 
7.4 Charles River Laboratories International, Inc. 
7.5 Crown Bioscience, Inc. 
7.6 Emerald BioStructures, Inc. 
7.7 Evotec AG 
7.8 Kinetic Discovery Limited
7.9 Proteros Fragments GmbH 
7.10 Sprint Bioscience 
7.11 Structure Based Design, Inc.  
7.12 Sygnature Discovery